A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors

por Brænne, Ingrid, Willenborg, Christina, Tragante, Vinicius, Kessler, Thorsten, Zeng, Lingyao, Reiz, Benedikt, Kleinecke, Mariana, von Ameln, Simon, Willer, Cristen J., Laakso, Markku, Wild, Philipp S., Zeller, Tanja, Wallentin, Lars, Franks, Paul W., Salomaa, Veikko, Dehghan, Abbas, Meitinger, Thomas, Samani, Nilesh J., Asselbergs, Folkert W., Erdmann, Jeanette, Schunkert, Heribert
Publicado 2017

Account of the Efficacy of Sugar of Lead, in a Case of Epilepsy. In a Letter to Dr. R. Coxe, of Philadelphia

por Spence, T. R. P.
Publicado 1807

HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression

por Wang, Y. X., Li, Y. Z., Zhang, Z. Y., Wang, J. Q., Cui, J., Qian, X. L.
Publicado 2017

Correction to: AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity

por Saliba, Soraya Wilke, Marcotegui, Ariel R., Fortwängler, Ellen, Ditrich, Johannes, Perazzo, Juan Carlos, Muñoz, Eduardo, de Oliveira, Antônio Carlos Pinheiro, Fiebich, Bernd L.
Publicado 2018

Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer’s Disease

por Lee, Ju Youn, Han, Seung Hoon, Park, Min Hee, Baek, Bosung, Song, Im-Sook, Choi, Min-Koo, Takuwa, Yoh, Ryu, Hoon, Kim, Seung Hyun, He, Xingxuan, Schuchman, Edward H., Bae, Jae-Sung, Jin, Hee Kyung
Publicado 2018

PCR-based detection of Plasmodium falciparum in saliva using mitochondrial cox3 and varATS primers

por Lloyd, Yukie M., Esemu, Livo F., Antallan, Jovikka, Thomas, Bradley, Tassi Yunga, Samuel, Obase, Bekindaka, Christine, Nana, Leke, Rose G. F., Culleton, Richard, Mfuh, Kenji Obadiah, Nerurkar, Vivek R., Taylor, Diane Wallace
Publicado 2018

Instances of erroneous DNA barcoding of metazoan invertebrates: Are universal cox1 gene primers too “universal”?

por Mioduchowska, Monika, Czyż, Michał Jan, Gołdyn, Bartłomiej, Kur, Jarosław, Sell, Jerzy
Publicado 2018

Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury

por Jones, Melissa, Wen, Jie, Selvaraj, Prabhuanand, Tanaka, Mikiei, Moran, Sean, Zhang, Yumin
Publicado 2018

Assessment of the fitness of Cox and parametric regression models of survival distribution for Iranian breast cancer patients' data

por Mohseny, Maryam, Shekarriz-Foumani, Reza, Amiri, Parastoo, Vejdani, Marjan, Farshidmehr, Pezhman, Mahmoudabadi, Hossein Zabihi, Amanpour, Farzaneh, Mohaghegh, Pegah, Tajdini, Farzad, Sayarifard, Azadeh, Davoudi-Monfared, Esmat
Publicado 2019

Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2

por Cao, Yuzhu, Shi, Hang, Sun, Zhiguang, Wu, Jiawei, Xia, Yawen, Wang, Yufei, Wu, Yuanyuan, Li, Xiaoman, Chen, Wenxing, Wang, Aiyun, Lu, Yin
Publicado 2019

Design, synthesis, and evaluation of novel 2-phenylpropionic acid derivatives as dual COX inhibitory-antibacterial agents

por Karaca Gençer, Hülya, Acar Çevik, Ulviye, Kaya Çavuşoğlu, Betül, Sağlık, Begüm Nurpelin, Levent, Serkan, Atlı, Özlem, Ilgın, Sinem, Özkay, Yusuf, Kaplancıklı, Zafer Asım
Publicado 2017

c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer

por Xie, Ruting, Yang, Yongzhi, Zhang, Huizhen, Liu, Hu, Guo, Jing, Qin, Huanlong, Ma, Yanlei, Goel, Ajay, Li, Xinxiang, Wei, Qing
Publicado 2019

Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”

por Walker, Chris
Publicado 2019

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake

por Behling, Felix, Ries, Vanessa, Skardelly, Marco, Gepfner-Tuma, Irina, Schuhmann, Martin, Ebner, Florian-Heinrich, Tabatabai, Ghazaleh, Bornemann, Antje, Schittenhelm, Jens, Tatagiba, Marcos
Publicado 2019

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells

por Xiao, Juanjuan, Wang, Fei, Lu, Hui, Xu, Sanpeng, Zou, Ling, Tian, Qin, Fu, Yang, Lin, Xuan, Liu, Lin, Yuan, Ping, Ni, Xiaofang, Ma, Tengfei, Zeng, Fanfan, Xue, Peipei, Xiu, Ruijuan, Zhang, Jianmin, Ji, Xinying, Hu, Hongbo, Lu, Shangyun, Dai, Hongtian, Li, Yuan, Chu, Qian, Zhao, Xia, Duan, Qiuhong, Zhu, Feng
Publicado 2019

Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan

por Lu, Chieh-Hua, Chung, Chi-Hsiang, Lee, Chien-Hsing, Su, Sheng-Chiang, Liu, Jhih-Syuan, Lin, Fu-Huang, Tsao, Chang-Huei, Hsieh, Po-Shiuan, Hung, Yi-Jen, Hsieh, Chang-Hsun, Chien, Wu-Chien
Publicado 2019

Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

por Liu, Yani, Zhang, Rui, Li, Zhongfang, Zhou, Jiali, Yang, Tingyu, Yang, Chunxiao, Huang, Xixi, Zhang, Yu, Shi, Shaojun
Publicado 2019

Reasons why osteoarthritis predicts mortality: path analysis within a Cox proportional hazards model

por Wilkie, Ross, Parmar, Simran Singh, Blagojevic-Bucknall, Milica, Smith, Diane, Thomas, Martin J, Seale, Bethany Jane, Mansell, Gemma, Peat, George
Publicado 2019

Thiazolidinedione Derivative Suppresses LPS-induced COX-2 Expression and NO Production in RAW 264.7 Macrophages

por Rezaei, Mehrnaz, Ghafouri, Hossein, Aghamaali, Mahmood Reza, Shourian, Mostafa
Publicado 2019

Generating Survival Times Using Cox Proportional Hazards Models with Cyclic and Piecewise Time-Varying Covariates

por Huang, Yunda, Zhang, Yuanyuan, Zhang, Zong, Gilbert, Peter B.
Publicado 2020